There are situations where, despite having embryos of excellent quality, patients face difficulties in achieving pregnancy due to repeated implantation failures.
URCrea units are specially equipped to address these circumstances, with specialized units dedicated to the study of Implantation Failure and Repeated Miscarriages.
This team is dedicated to diagnosing and conducting tests to analyze these cases, which often involve uncommon pathologies and situations of infertility of unknown origin.
This study is recommended for patients who have experienced two or three consecutive pregnancy losses, occurring before the twentieth week of gestation and with a fetal weight equal to or less than 500 grams.
At URCrea, we tailor each approach to the specific needs of each patient, considering factors such as age, personal and family history, as well as any circumstances that may contribute to early pregnancy losses.
In many cases, the causes of repeated miscarriages are related to genetic factors and antiphospholipid syndrome. It is estimated that about 50% of miscarriages are associated with genetic and chromosomal abnormalities in embryos.
In our specialized units, we perform embryonic genetic studies through Preimplantation Genetic Diagnosis (PGD). Additionally, we analyze both male and female karyotypes to identify possible chromosomal abnormalities that may predispose to miscarriage.
The patients’ own immunological factors can trigger responses that hinder the proper development of pregnancy.
After conducting comprehensive tests and studies, treatment is personalized according to the medical history and specific conditions of each patient. Various immunological factors can influence embryonic implantation.
Our specialized unit in Reproductive Immunology investigates the metabolic, immunological, and endocrine mechanisms involved in these situations to offer the most appropriate treatment in each case.
